Cargando…

Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process

Human mesenchymal stem cell (hMSC) therapies are currently progressing through clinical development, driving the need for consistent, and cost effective manufacturing processes to meet the lot‐sizes required for commercial production. The use of animal‐derived serum is common in hMSC culture but has...

Descripción completa

Detalles Bibliográficos
Autores principales: Heathman, Thomas R. J., Glyn, Veronica A. M., Picken, Andrew, Rafiq, Qasim A., Coopman, Karen, Nienow, Alvin W., Kara, Bo, Hewitt, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029583/
https://www.ncbi.nlm.nih.gov/pubmed/25727395
http://dx.doi.org/10.1002/bit.25582
_version_ 1782454534314917888
author Heathman, Thomas R. J.
Glyn, Veronica A. M.
Picken, Andrew
Rafiq, Qasim A.
Coopman, Karen
Nienow, Alvin W.
Kara, Bo
Hewitt, Christopher J.
author_facet Heathman, Thomas R. J.
Glyn, Veronica A. M.
Picken, Andrew
Rafiq, Qasim A.
Coopman, Karen
Nienow, Alvin W.
Kara, Bo
Hewitt, Christopher J.
author_sort Heathman, Thomas R. J.
collection PubMed
description Human mesenchymal stem cell (hMSC) therapies are currently progressing through clinical development, driving the need for consistent, and cost effective manufacturing processes to meet the lot‐sizes required for commercial production. The use of animal‐derived serum is common in hMSC culture but has many drawbacks such as limited supply, lot‐to‐lot variability, increased regulatory burden, possibility of pathogen transmission, and reduced scope for process optimization. These constraints may impact the development of a consistent large‐scale process and therefore must be addressed. The aim of this work was therefore to run a pilot study in the systematic development of serum‐free hMSC manufacturing process. Human bone‐marrow derived hMSCs were expanded on fibronectin‐coated, non‐porous plastic microcarriers in 100 mL stirred spinner flasks at a density of 3 × 10(5) cells.mL(−1) in serum‐free medium. The hMSCs were successfully harvested by our recently‐developed technique using animal‐free enzymatic cell detachment accompanied by agitation followed by filtration to separate the hMSCs from microcarriers, with a post‐harvest viability of 99.63 ± 0.03%. The hMSCs were found to be in accordance with the ISCT characterization criteria and maintained hMSC outgrowth and colony‐forming potential. The hMSCs were held in suspension post‐harvest to simulate a typical pooling time for a scaled expansion process and cryopreserved in a serum‐free vehicle solution using a controlled‐rate freezing process. Post‐thaw viability was 75.8 ± 1.4% with a similar 3 h attachment efficiency also observed, indicating successful hMSC recovery, and attachment. This approach therefore demonstrates that once an hMSC line and appropriate medium have been selected for production, multiple unit operations can be integrated to generate an animal component‐free hMSC production process from expansion through to cryopreservation. Biotechnol. Bioeng. 2015;112: 1696–1707. © 2015 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
format Online
Article
Text
id pubmed-5029583
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50295832016-10-03 Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process Heathman, Thomas R. J. Glyn, Veronica A. M. Picken, Andrew Rafiq, Qasim A. Coopman, Karen Nienow, Alvin W. Kara, Bo Hewitt, Christopher J. Biotechnol Bioeng Articles Human mesenchymal stem cell (hMSC) therapies are currently progressing through clinical development, driving the need for consistent, and cost effective manufacturing processes to meet the lot‐sizes required for commercial production. The use of animal‐derived serum is common in hMSC culture but has many drawbacks such as limited supply, lot‐to‐lot variability, increased regulatory burden, possibility of pathogen transmission, and reduced scope for process optimization. These constraints may impact the development of a consistent large‐scale process and therefore must be addressed. The aim of this work was therefore to run a pilot study in the systematic development of serum‐free hMSC manufacturing process. Human bone‐marrow derived hMSCs were expanded on fibronectin‐coated, non‐porous plastic microcarriers in 100 mL stirred spinner flasks at a density of 3 × 10(5) cells.mL(−1) in serum‐free medium. The hMSCs were successfully harvested by our recently‐developed technique using animal‐free enzymatic cell detachment accompanied by agitation followed by filtration to separate the hMSCs from microcarriers, with a post‐harvest viability of 99.63 ± 0.03%. The hMSCs were found to be in accordance with the ISCT characterization criteria and maintained hMSC outgrowth and colony‐forming potential. The hMSCs were held in suspension post‐harvest to simulate a typical pooling time for a scaled expansion process and cryopreserved in a serum‐free vehicle solution using a controlled‐rate freezing process. Post‐thaw viability was 75.8 ± 1.4% with a similar 3 h attachment efficiency also observed, indicating successful hMSC recovery, and attachment. This approach therefore demonstrates that once an hMSC line and appropriate medium have been selected for production, multiple unit operations can be integrated to generate an animal component‐free hMSC production process from expansion through to cryopreservation. Biotechnol. Bioeng. 2015;112: 1696–1707. © 2015 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc. John Wiley and Sons Inc. 2015-04-20 2015-08 /pmc/articles/PMC5029583/ /pubmed/25727395 http://dx.doi.org/10.1002/bit.25582 Text en © 2015 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Heathman, Thomas R. J.
Glyn, Veronica A. M.
Picken, Andrew
Rafiq, Qasim A.
Coopman, Karen
Nienow, Alvin W.
Kara, Bo
Hewitt, Christopher J.
Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process
title Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process
title_full Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process
title_fullStr Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process
title_full_unstemmed Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process
title_short Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process
title_sort expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum‐free microcarrier process
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029583/
https://www.ncbi.nlm.nih.gov/pubmed/25727395
http://dx.doi.org/10.1002/bit.25582
work_keys_str_mv AT heathmanthomasrj expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess
AT glynveronicaam expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess
AT pickenandrew expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess
AT rafiqqasima expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess
AT coopmankaren expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess
AT nienowalvinw expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess
AT karabo expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess
AT hewittchristopherj expansionharvestandcryopreservationofhumanmesenchymalstemcellsinaserumfreemicrocarrierprocess